AbCellera to Present Virtually at the BofA Securities – Tech Solutions for Drug Discovery Conference

Rhea-AI Summary

AbCellera (Nasdaq: ABCL) announced its participation in the BofA Securities – Tech Solutions for Drug Discovery Conference on September 20, 2021, at 9:00 a.m. Pacific Time. Executives from AbCellera will present virtually, with a live audio webcast accessible through the company's Investor Relations website. A replay will be available post-presentation. AbCellera specializes in antibody discovery to assist drug developers in combating diseases.

VANCOUVER--(BUSINESS WIRE)-- AbCellera (Nasdaq: ABCL) today announced that executives from the Company will present virtually at the BofA Securities  – Tech Solutions for Drug Discovery Conference on Monday, September 20, 2021, at 9:00 a.m. Pacific Time.

A live audio webcast of the presentation may be accessed through a link that will be posted on AbCellera’s Investor Relations website. A replay will be available through the same link following the presentation.

About AbCellera Biologics Inc.

AbCellera is a technology company that searches, decodes, and analyzes natural immune systems to find antibodies that its partners can develop into drugs to prevent and treat disease. AbCellera partners with drug developers of all sizes, from large pharmaceutical to small biotechnology companies, empowering them to move quickly, reduce costs, and tackle the toughest problems in drug development. For more information, please visit www.abcellera.com.

Source: AbCellera Biologics Inc.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210910005540/en/

Inquiries

Media: Jessica Yingling, Ph.D.; media@abcellera.com, +1(236)521-6774

Business Development: Neil Berkley, Ph.D.; bd@abcellera.com, +1(604)559-9005

Investor Relations: Melanie Solomon; ir@abcellera.com, +1(778)729-9116

Source: AbCellera

FAQ

When will AbCellera present at the BofA Securities Conference?

AbCellera will present at the BofA Securities – Tech Solutions for Drug Discovery Conference on September 20, 2021, at 9:00 a.m. Pacific Time.

How can I access the AbCellera presentation?

The presentation can be accessed via a live audio webcast link on AbCellera's Investor Relations website.

What does AbCellera do?

AbCellera is a technology company focused on searching and analyzing natural immune systems to discover antibodies for drug development.

Who are AbCellera's partners in drug development?

AbCellera partners with both large pharmaceutical companies and small biotechnology firms to expedite drug development.

What is the stock symbol for AbCellera?

The stock symbol for AbCellera is ABCL.